| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 68885* | 2014 |
| Analysis of protein-coding genetic variation in 60,706 humans M Lek, KJ Karczewski, EV Minikel, KE Samocha, E Banks, T Fennell, ... Nature 536 (7616), 285-291, 2016 | 10581 | 2016 |
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction SM Haffner, S Lehto, T Rönnemaa, K Pyörälä, M Laakso New England journal of medicine 339 (4), 229-234, 1998 | 10366 | 1998 |
| “Effective” number of parties: a measure with application to West Europe M Laakso, R Taagepera Comparative political studies 12 (1), 3-27, 1979 | 6124 | 1979 |
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a … JA Dormandy, B Charbonnel, DJA Eckland, E Erdmann, ... The Lancet 366 (9493), 1279-1289, 2005 | 5374 | 2005 |
| Genetic studies of body mass index yield new insights for obesity biology AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ... Nature 518 (7538), 197-206, 2015 | 4877 | 2015 |
| Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α M Lagouge, C Argmann, Z Gerhart-Hines, H Meziane, C Lerin, F Daussin, ... Cell 127 (6), 1109-1122, 2006 | 4857 | 2006 |
| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial FIELD Study Investigators The Lancet 366 (9500), 1849-1861, 2005 | 4151 | 2005 |
| Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial JL Chiasson, RG Josse, R Gomis, M Hanefeld, A Karasik, M Laakso The Lancet 359 (9323), 2072-2077, 2002 | 3620 | 2002 |
| Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index EK Speliotes, CJ Willer, SI Berndt, KL Monda, G Thorleifsson, AU Jackson, ... Nature genetics 42 (11), 937-948, 2010 | 3615 | 2010 |
| Discovery and refinement of loci associated with lipid levels CJ Willer, EM Schmidt, S Sengupta, GM Peloso, S Gustafsson, S Kanoni, ... Nature genetics 45 (11), 1274, 2013 | 3049* | 2013 |
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ... Nature genetics 42 (2), 105-116, 2010 | 2587 | 2010 |
| Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JL Chiasson, RG Josse, R Gomis, M Hanefeld, A Karasik, M Laakso, ... Jama 290 (4), 486-494, 2003 | 2344 | 2003 |
| Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk CKDGen Consortium, KidneyGen Consortium, EchoGen consortium, ... Nature 478 (7367), 103-109, 2011 | 2343 | 2011 |
| Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes E Zeggini, LJ Scott, R Saxena, BF Voight, JL Marchini, T Hu, ... Nature genetics 40 (5), 638-645, 2008 | 2315 | 2008 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2276 | 2006 |
| Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC ... Nature genetics 44 (9), 981-990, 2012 | 2207 | 2012 |
| Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis BF Voight, LJ Scott, V Steinthorsdottir, AP Morris, C Dina, RP Welch, ... Nature genetics 42 (7), 579-589, 2010 | 2204 | 2010 |
| Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of … L Rydén, E Standl, M Bartnik, G Van den Berghe, J Betteridge, ... European heart journal 28 (1), 88-136, 2007 | 2157 | 2007 |
| Defining the role of common variation in the genomic and biological architecture of adult human height AR Wood, T Esko, J Yang, S Vedantam, TH Pers, S Gustafsson, AY Chu, ... Nature genetics 46 (11), 1173-1186, 2014 | 2134 | 2014 |
Michael BoehnkeProfessor of Biostatistics, University of MichiganDirección de correo verificada de umich.edu
